Caspase

Caspases (cysteine-aspartic proteases) are a family of enzymes that play fundamental roles in apoptosis, inflammation, and a growing list of cell fate and homeostatic processes. They are synthesized as inactive precursors (zymogens) and activated by specific signaling complexes in response to developmental cues or stress signals. Caspases can be classified as initiators (e.g., caspase-8, -9), executioners/effectors (e.g., caspase-3, -6, -7), or inflammatory caspases (e.g., caspase-1, -4, -5, -11), depending on their primary roles. Dysregulation of caspase activity is implicated in numerous diseases, including cancer, neurodegeneration, autoimmune disorders, and infections. Although caspases themselves (as a family) are considered key therapeutic targets, "Caspase stimulant" is not a specific canonical target—it refers to compounds that activate or enhance caspase activity and is not the name of a specific molecule or receptor. There is currently no single molecule or protein officially named "Caspase stimulant"; instead, individual caspases or caspase activation pathways are referenced in drug development and research. Important note on correctness: The query "Caspase stimulant" is not a canonical target name. It is a functional descriptor ("stimulant" of caspase activity) rather than a specific protein, gene, or receptor. The correct approach is to refer to individual caspase family members (e.g., "Caspase-3", "Caspase-8") or pathways leading to caspase activation. For structured data or drug discovery, a specific caspase (such as "Caspase-3" or "Caspase-8") should be referenced, not the functional class "Caspase stimulant".

Other names

Cysteine-aspartic proteaseCysteine-dependent aspartate-directed proteaseCysteine aspartaseCASP

Activation (stimulating apoptotic pathways); Inhibition (blocking apoptosis or inflammation); Indirect modulation via upstream pathways (e.g., death receptors, inflammasome components)